World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
126
Citations
60566
World Ranking
2951
National Ranking
301

Overview

Robert A. Scott is affiliated with the University of Cambridge in the United Kingdom. Their research spans several areas within biochemistry, genetics, and molecular biology, with contributions touching on molecular biology, materials chemistry, archeology, cell biology, and inorganic chemistry.

Their recent publications include:

  • Spectroscopic characterization of Mn2+ and Cd2+ coordination to phosphorothioates in the conserved A9 metal site of the hammerhead ribozyme, 2022, Journal of Inorganic Biochemistry
  • Action painting under spectroscopic light: Excited-state exchange interactions behind the vibrant blue in Jackson Pollock's Number 1A, 1948, 2025, Proceedings of the National Academy of Sciences

Frequent coauthors who have collaborated with Robert A. Scott include:

  • Laura M. Hunsicker-Wang
  • M. Vogt
  • Charles G. Hoogstraten
  • Nathaniel J. Cosper
  • Audrey M. Davenport

The most common publication venues for their work are:

  • Journal of Inorganic Biochemistry
  • Proceedings of the National Academy of Sciences

Main fields of study connected to Robert A. Scott's work encompass biochemistry, genetics, and molecular biology.

Subfields explored in their research include:

  • Molecular Biology
  • Materials Chemistry
  • Archeology
  • Cell Biology
  • Inorganic Chemistry

The primary topics Robert A. Scott has investigated are:

  • RNA and protein synthesis mechanisms
  • Advanced biosensing and bioanalysis techniques
  • Corrosion behavior and inhibition
  • Cultural heritage materials analysis
  • Melanin and skin pigmentation
  • Pigment synthesis and properties

Best Publications

  • Defining the role of common variation in the genomic and biological architecture of adult human height

    Andrew R. Wood;Tonu Esko;Jian Yang;Sailaja Vedantam

  • Genetic studies of body mass index yield new insights for obesity biology

    Adam E. Locke;Bratati Kahali;Sonja I. Berndt;Anne E. Justice

  • Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps.

    Anubha Mahajan;Daniel Taliun;Matthias Thurner;Neil R. Robertson

  • Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits.

    Evangelos Evangelou;Evangelos Evangelou;Helen R. Warren;Helen R. Warren;David Mosen-Ansorena;Borbala Mifsud

  • Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors

    Stephen Burgess;Robert A. Scott;Nicholas J. Timpson;George Davey Smith

  • The genetic architecture of type 2 diabetes

    Christian Fuchsberger;Christian Fuchsberger;Jason A. Flannick;Jason A. Flannick;Tanya M. Teslovich;Anubha Mahajan

  • Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries

    Mary F. Feitosa;Aldi T. Kraja;Daniel I. Chasman;Yun J. Sung

  • Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility.

    Anubha Mahajan;Min Jin Go;Weihua Zhang;Jennifer E. Below

  • A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance.

    Alisa K. Manning;Alisa K. Manning;Alisa K. Manning;Robert A. Scott;Jonna L. Grimsby

  • Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways

    Robert A Scott;Vasiliki Lagou;Ryan P Welch;Eleanor Wheeler

  • A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia

    Dirk J. Blom;Tomas Hala;Michael Bolognese;Michael J. Lillestol

  • Association between alcohol and cardiovascular disease:Mendelian randomisation analysis based on individual participant data

    Michael V Holmes;Michael V Holmes;Caroline E Dale;Luisa Zuccolo;Richard J Silverwood

  • HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.

    Daniel I Swerdlow;David Preiss;Karoline B Kuchenbaecker;Michael Holmes

  • An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans

    Robert A. Scott;Laura J. Scott;Reedik Mägi;Letizia Marullo

  • Low-Density Lipoprotein Cholesterol–Lowering Effects of AMG 145, a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease in Patients With Heterozygous Familial Hypercholesterolemia The Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) Randomized Trial

    Frederick Raal;Rob Scott;Ransi Somaratne;Ian Bridges

  • Physical activity attenuates the influence of FTO variants on obesity risk: A meta-analysis of 218,166 adults and 19,268 children

    Tuomas O. Kilpeläinen;Lu Qi;Soren Brage;Stephen J. Sharp

  • The UK10K project identifies rare variants in health and disease

    Klaudia Walter;Josine L. Min;Jie Huang;Lucy Crooks

  • Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits

    Evangelos Evangelou;Helen R. Warren;David Mosen-Ansorena;Borbala Mifsu

  • The genetic architecture of type 2 diabetes

    Christian Fuchsberger;Jason Flannick;Tanya M. Teslovich;Anubha Mahajan

  • Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility

    Anubha Mahajan;Min Jin Go;Weihua Zhang;Jennifer E. Below

Frequent Co-Authors

Nicholas J. Wareham
Nicholas J. Wareham University of Cambridge
Claudia Langenberg
Claudia Langenberg Queen Mary University of London
Paul W. Franks
Paul W. Franks Lund University
John C. Chambers
John C. Chambers Guy's and St Thomas' NHS Foundation Trust
Jaspal S. Kooner
Jaspal S. Kooner Imperial College London
Andrew P. Morris
Andrew P. Morris University of Liverpool
Jian'an Luan
Jian'an Luan University of Cambridge
Tonu Esko
Tonu Esko University of Tartu
Weihua Zhang
Weihua Zhang Imperial College London
Erik Ingelsson
Erik Ingelsson Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA isn't limited to becoming a doctor. There are multiple online degree options that open doors to diverse healthcare roles while offering flexibility for various life situations.

For those interested in leadership roles, healthcare administration degree programs provide a fast track into hospital management, policy, and network administration. If you're already a registered nurse, adn to np bridge programs help advance your clinical expertise and open up opportunities as a nurse practitioner.

Nutrition science is another rewarding field. With an online dietitian degree, you can work in hospitals, public health, or private practice, promoting healthy living and disease prevention.

Finally, those seeking high-level administrative careers may consider enrolling in one of the best online mha programs, which prepare graduates to lead healthcare organizations efficiently and ethically.

Each of these online pathways offers unique opportunities to make a real impact in the health sector while matching different interests and career goals.

Best Scientists Citing Robert A. Scott

Trending Scientists